The first issue of ACS Nano for 2017 features an article on the “Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.” The article, co-authored by NCL’s Senior Immunologist, Marina Dobrovolskaia, along with several other well-known names in the field, summarizes the topics of discussion from a recent meeting on the subject. The two-day workshop was held in Brekenridge, Colorado in July 2016 and featured expert speakers from academia and industry, as well as clinicians. Some of the topics summarized include interaction with the complement system, clearance by the MPS, enhancing transport in the stroma, and tumor targeting.
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
Anchordoquy, T.J., Barenholz, Y., Boraschi, D., Chorny, M., Decuzzi, P., Dobrovolskaia, M.A., Farhangrazi, Z.S., Farrell, D., Gabizon, A., Ghandehari, H., Godin, B., La-Beck, N.M., Ljubimova, J., Moghimi, S.M., Pagliaro, L., Park, J.H., Peer, D., Ruoslahti, E., Serkova, N.J., and Simberg, D.
ACS Nano. 2017, 11(1), 12-18.